Life-longevity elderly-derived saliva combined lactobacillus and application thereof

The invention discloses a longevity elderly-derived combined lactobacillus salivarius and application thereof, and is characterized in that the combined lactobacillus salivarius QS104 is classified and named as combined lactobacillus salivarius, is preserved in China General Microbiological Culture...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WANG DEHUA, YANG CHENG, ZHU JIAOLIN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention discloses a longevity elderly-derived combined lactobacillus salivarius and application thereof, and is characterized in that the combined lactobacillus salivarius QS104 is classified and named as combined lactobacillus salivarius, is preserved in China General Microbiological Culture Collection Center (CGMCC) on January 2, 2024, has a preservation number of CGMCC No.29484, and has a preservation number of CGMCC No.29484. The combined lactobacillus salivarius QS104 has a preservation number of CGMCC No.29484. The combined lactobacillus salivarius QS104 has a preservation number of CGMCC No.29484. The invention also discloses application of the saliva combined lactobacillus in preparation of uric acid-reducing drugs, antioxidants, blood sugar-reducing drugs and intestinal flora regulators. The saliva combined lactobacillus has the advantages of reducing uric acid, reducing blood sugar, resisting oxidation and regulating intestinal functions. 本发明公开了一种长寿老人源唾液联合乳杆菌及其应用，特点是该唾液联合乳杆菌QS104分类命名为唾液联合乳杆菌Li